Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
Regular paperDietary modification of fatty acid and prostaglandin synthesis in the rat: Effect of variations in the level of dietary fat
Abstract
Dietary supplements with safflower oil, linseed oil, cod liver oil and hydrogenated coconut oil were given to rats at levels of 5, 20 and 40 energy % to simultaneously assess the effects of both type and level of dietary fat on tissue fatty acid composition and prostanoid synthesis. There was no significant change in weight gain or blood pressure between the dietary groups after the 4-week dietary regimen. The liver oil and linseed oil diets depressed the arachidonic acid content of kidney phospholipids at all levels of supplementation. The arachidonic acid content of plasma lipids was significantly elevated in animals on the safflower oil diet at 20 and 40 energy % while those on the same level of liver oil diet showed a marked reduction in arachidonic acid. Whole blood synthesis of thromboxane B2 varied significantly at all levels of fat supplementation, with the 20 energy % safflower oil fed group showing maximally enhanced thromboxane B2 production compared to the coconut oil group (P < 0.001). Conversely, the liver oil groups showed depressed thromboxane B2 synthesis at 20 and 40 energy % (P < 0.01) compared to the coconut oil group and at 5 energy % compared to the safflower oil group (P< 0.05). Production of 6-ketoprostaglandin F1α and prostaglandin E2 by incubated kidney homogenates only differed significantly between the dietary groups at 40 energy %. Urinary excretion of 6-ketoprostaglandin F1α was increased by 45% and 55% in rats fed the safflower oil diet at 20 and 40 energy %, respectively compared to the saturated fat diet, while in the liver oil groups excretion was reduced by 20% and 32%. Dietary suppression of prostanoid synthesis is explained in part by changes in available arachidonic acid and competitive inhibition of cyclooxygenase by (n − 3) fatty acids. Thus, minor changes in dietary fat can readily alter tissue fatty acid composition, but both the extent and nature of changes in phospholipid and prostanoid metabolism vary markedly according to the tissue site.
References (39)
- H. Mohrhauer et al.
J. Nutr.
(1963) - D.H. Hwang et al.
J. Clin. Nutr.
(1980) - W. Siess et al.
Lancet
(1980) - K.M. Fine et al.
J. Nutr.
(1981) - J. Dupont et al.
J. Nutr.
(1980) - W.R. Morrison et al.
J. Lipid Res.
(1964) - D.P. Mahoney et al.
Prostaglandin Leukotriene Med.
(1983) - S.W. Needleman et al.
Prostaglandins
(1982) - J. Dyerberg et al.
Lancet
(1979) - A. Socini et al.
Prostaglandins
(1983)
Biochim. Biophys. Acta
Lipids
Ateriosclerosis
Nutr. Rev.
Acta Med. Scan.
Lipids
Arch. Int. Physiol. Biochim.
Cited by (88)
Elevated n-3/n-6 PUFA ratio in early life diet reverses adverse intrauterine kidney programming in female rats
2022, Journal of Lipid ResearchIntrauterine growth restriction (IUGR) predisposes to chronic kidney disease via activation of proinflammatory pathways, and omega-3 PUFAs (n-3 PUFAs) have anti-inflammatory properties. In female rats, we investigated 1) how an elevated dietary n-3/n-6 PUFA ratio (1:1) during postnatal kidney development modifies kidney phospholipid (PL) and arachidonic acid (AA) metabolite content and 2) whether the diet counteracts adverse molecular protein signatures expected in IUGR kidneys. IUGR was induced by bilateral uterine vessel ligation or intrauterine stress through sham operation 3.5 days before term. Control (C) offspring were born after uncompromised pregnancy. On postnatal (P) days P2–P39, rats were fed control (n-3/n-6 PUFA ratio 1:20) or n-3 PUFA intervention diet (N3PUFA; ratio 1:1). Plasma parameters (P33), kidney cortex lipidomics and proteomics, as well as histology (P39) were studied. We found that the intervention diet tripled PL-DHA content (PC 40:6; P < 0.01) and lowered both PL-AA content (PC 38:4 and lyso-phosphatidylcholine 20:4; P < 0.05) and AA metabolites (HETEs, dihydroxyeicosatrienoic acids, and epoxyeicosatrienoic acids) to 25% in all offspring groups. After ligation, our network analysis of differentially expressed proteins identified an adverse molecular signature indicating inflammation and hypercoagulability. N3PUFA diet reversed 61 protein alterations (P < 0.05), thus mitigating adverse IUGR signatures. In conclusion, an elevated n-3/n-6 PUFA ratio in early diet strongly reduces proinflammatory PLs and mediators while increasing DHA-containing PLs regardless of prior intrauterine conditions. Counteracting a proinflammatory hypercoagulable protein signature in young adult IUGR individuals through early diet intervention may be a feasible strategy to prevent developmentally programmed kidney damage in later life.
Health Benefits of Flaxseed
2011, Omega-3 Oils: Applications in Functional FoodsFlaxseed or linseed has been used for food and industrial fiber since ancient times. The terms, “flaxseed” and “linseed” are often used interchangeably, although North Americans use “flaxseed” to describe flax when it is eaten by humans and “linseed” to describe flax when it is used for industrial purposes, such as linoleum flooring. In Europe, the term, “flaxseed” describes the varieties grown for making linen. Flaxseed contains lipid (40%), protein (21%), dietary fiber (28%), ash (4%), and other soluble components such as sugars, phenolic acids, and lignans (ca 6%). The oil content in flaxseed represents between 29 and 45% of the seed depending on the cultivar, location, and agroclimatic conditions. This chapter focuses on the health benefits of flaxseed. The main nutritional advantage of flaxseed oil is related to the high level of ALA in the oil (50%–60%). About 20% of the flaxseed is a mucilagenous hull. Flaxseed mucilage is comprised of gum-like polysaccharides containing acidic (54.5% rhamnose and 23.4% galactose) and neutral arabinoxylan (62.8% xylose). Flaxseed contains about 1%–2% total phenolic compounds, of which the lignan secoisolariciresinol diglucoside (SDG) is a major component. SDG is present in the seed as a mixture of oligomers with hydroxymethylglutaric acid having an average molecular weight of 4000 Da.
Incorporation and metabolism of dietary trans isomers of linolenic acid alter the fatty acid profile of rat tissues
2000, Journal of NutritionTo study the influence on lipid metabolism and platelet aggregation of the fatty acid isomerization that occurs during heat treatment, weanling rats were fed for 8 wk a diet enriched with 5% isomerized (experimental group) or normal (control group) canola oil. Geometrical isomers of α-linolenic acid representing 0.2 g/100 g of the experimental diet were incorporated into liver, platelets, aorta and heart, at the expense of their cis homologue and of 18:2(n-6). The major isomer, 9c,12c,15t-18:3, was also metabolized to 5c,8c,11c,14c,17t-20:5 and to an unknown compound, found in liver, platelets and aorta, which has been identified tentatively as 7c,10c,13c,16c,19t-22:5. The greater 20:4(n-6)/18:2(n-6) ratio in the liver, platelets and heart of the experimental group than the control group indicated an enhancement of desaturation activities. This induced a higher content of long-chain (n-6) fatty acids in the experimental group. Platelet aggregation tended to be slightly higher (P = 0.065) in the experimental group. We conclude that 0.2 g of trans isomers of α-linolenic acid per 100 g of diet was sufficient to be incorporated and metabolized, thus altering the fatty acid profile of rat tissues.
Omega-3 fatty acids as cancer chemopreventive agents
1999, Pharmacology and TherapeuticsThere is both epidemiologic and experimental evidence that the long-chain omega-3 fatty acids (FAs), which occur at high levels in some fish oils, exert protective effects against some common cancers, notably those of breast, colon, and, perhaps, prostate. Multiple mechanisms are involved in this chemopreventive activity, including suppression of neoplastic transformation, cell growth inhibition and enhanced apoptosis, and antiangiogenicity; however, a common feature of most of these biological effects is the inhibition of eicosanoid production from omega-6 FA precursors. Several of the known risk factors for breast, and colon, cancer may be favorably modified by dietary omega-3 FA supplementation, and the implementation of clinical chemoprevention trials is now feasible.
Adipose tissue and the effects of fat and calories on breast tumorigenesis in rats
1995, The Journal of Nutritional BiochemistryA high fat diet fed ad libitum will promote breast tumorigenesis in rats while caloric restriction of the same high fat diet counteracts this promotional effect. The present study examined the effects of dietary fat and calorie intake on adipose tissue weight and fatty acid composition and on tumor incidence and development. The sites of adipose tissue chosen were the mammary fat pad, representing adipose tissue in the immediate location of the studied tumor, and the abdominal fat depot which in humans has been associated with an increased risk of breast cancer. High (20% corn oil) and low (5% corn oil) fat test diets were offered ad libitum and at 40% restriction levels. In agreement with prior studies, caloric restriction of both high and low fat diets led to marked decreases in tumor incidence (63 to 68% versus 21%), tumor burden (1.84 to 2.05 versus 0.37 to 0.43 tumors/rat), and tumor weight (7.1 to 11.9 versus 1.4 to 2.2 g) at the time of sacrifice (133 days post-DMBA). While final body weights were reduced in proportion to the level of caloric restriction (290 to 291 g versus 184 to 201 g), abdominal fat (8.8 to 9.2 versus 0.9 to 1.6 g), and mammary fat weights (3.1 to 4.1 versus 0.7 to 2.0 g) were reduced markedly in association with the decrease in tumorigenesis. While both tumor and mammary fat were enriched with linoleate reflecting the fatty acid composition of dietary fat, the ratio of arachidonic acid to linoleic acid was higher in tumor tissue than in surrounding normal mammary tissue in both the phospholipid (0.78 versus 0.18) and neutral lipid fractions (0.22 versus 0.03). These observations are consistent with the concept that increases in fat tissue mass in abdominal and mammary fat depots may mediate some of the promotional effects of high fat and high calorie diets. Restriction of dietary fat and calories to reduce body fat and strategies to modify the composition of stored lipids in fat depots may offer nutritional approaches to breast cancer prevention and treatment.
Is the reduction of myocardial infarct size by dietary fish oil the result of altered platelet function?
1994, American Heart JournalSprague-Dawley rats fed a diet containing 12% fish oil (18% eicosapentaenoic acid [EPA] and 12% docosahexaenoic acid [DHA]), for 1 week (group I, n = 9) or 8 weeks (group III, n = 42) and controls (group II, n = 8; group IV, n = 36, respectively) were subjected to 35 minutes of left coronary artery occlusion followed by 120 minutes of reperfusion. Compared to the controls, infarct size was significantly reduced in group III (15% ± 2%, n = 42 vs 34% ± 4%, n = 36; p < 0.001; infarct mass/risk area ×100%), but no change in group I (39% ± 5%, n = 9 vs 35% ± 5%, n = 8; p = not significant). Bleeding time was prolonged in group III (290 ± 73 sec) compared to group IV (99 ± 10 sec, p = 0.015). ω-3 fatty acid (EPA and DHA) levels in platelets were significantly higher in the rats fed 8 weeks of fish oil (group III) compared to the controls (group IV) and the rats fed 8 weeks of fish oil and then a regular diet until bleeding time normalized (group V) (7.2% ± 0.6% vs 1.2% ± 0.2% and 4.9% ± 0.5%; 3.8% ± 0.7% vs 1.8% ± 0.3% and 2.8% ± 0.6%, p < 0.001 and 0.05, respectively). These data indicate that long-term (8 weeks) dietary fish oil supplementation significantly reduces infarct size; short-term (1 week) does not. This reduction of infarct size appears to correlate with altered platelet function and EPA and DHA levels in platelets.